This is to inform that due to some circumstances beyond the organizer control, “International Conference on Medicinal Chemistry, Computer Aided Drug Design and Delivery” (MCADD 2023) Hybrid event during September 14-16, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at medicinal-chemistry@magnusconference.com or call + 1 (702) 988 2320.
Molecular biology is the study of the content, structure, and interactions of cellular molecules – such as nucleic acids and proteins – that carry out the biological processes that are required for the cell's functioning and maintenance. Scientific advancements in various areas are expanding our understanding of biological systems and how they relate to human disease. Medicinal chemistry is one of the most important factors in the development of new medications, since the design and synthesis of novel molecules has resulted in the development of numerous drugs. Chemical biology has developed as a major contributor to the knowledge of biological systems and is becoming a vital aspect of drug discovery, as it sits at the intersection of many fields. Bringing chemistry and biology closer together and blurring the distinctions between disciplines is opening up new avenues for probing and understanding biology; both disciplines play critical roles and must join forces and collaborate efficiently to maximise their influence. The full potential of chemical and molecular biology will then be realised, resulting in the discovery of transformational medications to treat patients.
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt